Imagine trying to breathe through a plastic bag. You struggle. Your heart starts to race. Your head gets dizzy. And all you did was stroll through a park full of blooming flowers. Asthma is one of the ...

The FDA approved depemokimab (Exdensur) as the first ultra-long-acting biologic with twice-yearly dosing approved for patients with severe asthma with an eosinophilic phenotype, GSK announced.

Chinese scientists have developed a groundbreaking cell therapy that could provide long-term relief for asthma patients with just a single shot. This new treatment, which has shown promising results ...

The flu season has passed, but here's some important news for parents to arm themselves with before next fall. A new study published in Pediatrics on June 4 said a flu shot is key for children with ...

Those trendy weight loss shots everyone’s talking about? Turns out they might do more than shrink your waistline — they could help you breathe easier too. New research involving 60,000 people just ...

Allergies affect millions of Americans each year, causing symptoms like sneezing, congestion, itchy eyes, fatigue, and even asthma flare ups. For many patients, over-the-counter medications or nasal ...

ATLANTA — Children with asthma should get flu shots to protect them, but only 3 in 10 do, U.S. health officials said Thursday. "We were surprised at how low the number was," said Susan Brim of the U.S ...

The U.S. Food and Drug Administration (FDA) has approved Exdensur, a twice-yearly severe asthma treatment developed by pharmaceutical company GSK.

This year’s top asthma and respiratory disorder story focused on the pushback from multiple advocacy groups following ...

Coughing and wheezing can leave anyone wondering whether it is asthma or bronchitis at play. Both of these respiratory issues ...